A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
Ask your healthcare provider to check for drug interactions
Si tratta di un tasso del 14,8% ogni 100.000 adolescenti, contro il 9,9 del 2023: cifre in crescita, ma che coinvolgono un numero relativamente basso di ragazzi (15.000 circa contro i 23.000 obesi stimati su 100.000)
Understanding your peptide genetic profile means your PlexusDx provider can recommend tirzepatide specifically if your genetics suggest good tolerability, or suggest an alternative like semaglutide if your profile indicates higher GI sensitivity
These patches occur when skin cells multiply faster due to high insulin levels or hormonal disturbances